Press coverage about Castlight Health (NYSE:CSLT) has trended somewhat positive on Tuesday, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Castlight Health earned a news sentiment score of 0.08 on Accern’s scale. Accern also gave news coverage about the software maker an impact score of 45.4802198023496 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
These are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:
- Castlight Health (CSLT) Rating Lowered to Hold at BidaskClub (americanbankingnews.com)
- Castlight Health (CSLT) Stock Rating Upgraded by ValuEngine (americanbankingnews.com)
- $36.02 Million in Sales Expected for Castlight Health (CSLT) This Quarter (americanbankingnews.com)
- Castlight Health (CSLT) & Zynga (ZNGA) Critical Review (americanbankingnews.com)
- Castlight Health Inc (CSLT) Expected to Post Earnings of -$0.08 Per Share (americanbankingnews.com)
CSLT has been the subject of a number of analyst reports. Zacks Investment Research downgraded shares of Castlight Health from a “buy” rating to a “hold” rating in a research report on Monday, January 1st. Cantor Fitzgerald upgraded shares of Castlight Health from a “neutral” rating to an “overweight” rating and set a $5.00 price objective for the company in a research report on Tuesday, January 30th. Chardan Capital reiterated a “buy” rating and issued a $5.75 price objective (down previously from $6.30) on shares of Castlight Health in a research report on Thursday, February 22nd. Finally, ValuEngine upgraded shares of Castlight Health from a “strong sell” rating to a “sell” rating in a research report on Wednesday, April 4th. Four analysts have rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $5.04.
Castlight Health (NYSE:CSLT) last released its earnings results on Wednesday, February 21st. The software maker reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.01. The business had revenue of $37.00 million during the quarter, compared to analysts’ expectations of $36.36 million. Castlight Health had a negative net margin of 42.28% and a negative return on equity of 28.76%. The company’s quarterly revenue was up 23.7% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.01) earnings per share. analysts expect that Castlight Health will post -0.32 earnings per share for the current year.
In other news, CEO John C. Doyle sold 10,644 shares of the business’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $3.63, for a total transaction of $38,637.72. Following the completion of the sale, the chief executive officer now owns 157,422 shares of the company’s stock, valued at $571,441.86. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Mangini Siobhan Nolan sold 18,201 shares of the business’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $3.63, for a total transaction of $66,069.63. Following the sale, the chief financial officer now directly owns 120,788 shares of the company’s stock, valued at approximately $438,460.44. The disclosure for this sale can be found here. Insiders have sold 33,184 shares of company stock valued at $120,762 in the last three months. Corporate insiders own 24.38% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect Castlight Health (CSLT) Stock Price” was first reported by Week Herald and is the sole property of of Week Herald. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this report can be read at https://weekherald.com/2018/04/17/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-castlight-health-cslt-stock-price.html.
About Castlight Health
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.